75 results on '"Picchio M"'
Search Results
2. MO-01.8 - EXTERNAL VALIDATION OF AN 18F-FDG-PET RADIOMIC MODEL PREDICTING CANCER-SPECIFIC SURVIVAL AFTER RADIOTHERAPY FOR OROPHARYNGEAL CANCER
3. P126 - Extended Nodal Radiotherapy for Prostate Cancer Lymph-Nodal Relapse Guided with [11C]-Choline PET/CT: ten-year results in patients enrolled in a prospective trial
4. PD-0400 External validation of a PET radiomic model predicting outcome after RT for oropharyngeal cancer
5. Prognostic Significance of Nodal Micrometastases in Patients with Non-functioning Pancreatic Neuroendocrine Tumors (NF-PanNETs)
6. SC267 - 99M-technetium-psma radio-guided surgery to detect nodal metastases in prostate cancer patients undergoing radical prostatectomy and extended pelvic lymph node dissection: a phase 2 prospective, single-institution study
7. [ 18f]fluorodeoxyglucose positron emission tomography as a useful indicator of metastatic gestational trophoblastic tumor: preliminary results in three patients
8. Value of [ 11C]choline-Positron Emission Tomography for Re-Staging Prostate Cancer: A Comparison With [ 18F]fluorodeoxyglucose-Positron Emission Tomography
9. V28 - 99m-technetium-psma radio-guided surgery to detect nodal metastases in prostate cancer patients undergoing radical prostatectomy and extended pelvic lymph node dissection: A phase 2 prospective, single-institution study
10. OL05 - Training and validation of a robust PET radiomic-based index predicting distant-relapse-free-survival after radiochemotherapy of patients with locally advanced pancreatic cancer
11. SC216 - The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial (NCT03955393)
12. T04.02.19 CLINICAL AND EPIDEMIOLOGICAL FEATURES OF ULCERATIVE COLITIS PATIENTS IN SARDINIA, ITALY – RESULTS FROM A MULTICENTER STUDY
13. T04.01.15 QUALITY OF LIFE AND PERCEPTION OF CARE FOR ULCERATIVE COLITIS PATIENTS IN SARDINIA: RESULTS OF A MULTICENTER OBSERVATIONAL STUDY
14. T02.01.20 SEROLOGY AS A DIAGNOSTIC TOOL FOR HELICOBACTER PYLORI INFECTION AND ASSOCIATED CHRONIC INFLAMMATION OF THE STOMACH: A POPULATION STUDY ON 524 PATIENTS
15. OC.08.4 RISK FACTORS FOR ENDOSCOPIC SEVERITY OF DIVERTICULAR DISEASE OF THE COLON AND ITS OUTCOME: A REAL-LIFE CASE-CONTROL STUDY
16. OC.08.3 THE “DICA” ENDOSCOPIC CLASSIFICATION FOR DIVERTICULAR DISEASE OF THE COLON SHOWS A SIGNIFICANT INTEROBSERVER AGREEMENT AMONG COMMUNITY ENDOSCOPISTS: AN INTERNATIONAL STUDY
17. EP-1907 Which FDG-PET features are robust enough for Radiomic studies in pancreatic cancer patients?
18. P.02.29 LONG-TERM EFFICACY OF RIFAXIMIN TO MANAGE THE SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE OF THE COLON
19. P.02.12 PREDICTIVE VALUE OF THE “DICA” ENDOSCOPIC CLASSIFICATION ON THE OUTCOME OF DIVERTICULAR DISEASE OF THE COLON: A 1-YEAR ANALYSIS FROM THE INTERNATIONAL, MULTICENTER, PROSPECTIVE STUDY
20. P.01.31 A COMPARISON OF DIFFERENT TREATMENTS FOR SYMPTOMATIC REFLUX ESOPHAGITIS: A REAL-LIFE STUDY
21. OC.03.3 THE “DICA” ENDOSCOPIC CLASSIFICATION FOR DIVERTICULAR DISEASE OF THE COLON SHOWS A SIGNIFICANT INTEROBSERVER AGREEMENT AMONG COMMUNITY ENDOSCOPISTS
22. 237. Robustness of FDG-PET radiomic features against tumor delineation in two clinical relevant scenarios
23. EP-1390: Salvage (postponed) hypofractionated tomotherapy for progressive MPM in patients with intact lungs
24. EP-1221: Hypoxia imaging with 18F-FAZA PET/CT in Radiotherapy Planning for High Grade Gliomas
25. P.06.14 EFFECTIVENESS AND SAFETY OF PYLERA® IN PATIENTS INFECTED BY HELICOBACTER PYLORI: A LARGE, PROSPECTIVE, REAL LIFE STUDY
26. P.05.7 EPIDEMIOLOGY OF DIVERTICULAR DISEASE OF THE COLON: A PRELIMINARY ANALYSIS FROM THE INTERNATIONAL “DICA” PROSPECTIVE STUDY
27. OC.13.3 ANALYSIS OF RISK FACTORS FOR RECURRENCE AFTER NEOADJUVANT RADIOTHERAPY AND LOCAL EXCISION OF RECTAL CANCER: THE PARTTLE STUDY
28. OC.03.4 IMPACT OF TREATMENTS ON FECAL MICROBIOTA AND FECAL METABOLIC PROFILING IN SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE OF THE COLON
29. 309 - The role of histologic subtypes in follow-up scheme of postsurgical kidney cancer patients
30. Unusual presentation of sarcoid-like reaction on bone marrow level associated with mediastinal lymphadenopathy on 18F-FDG-PET/CT resembling an early recurrence of Hodgkin's Lymphoma
31. EP-1678: Are PET radiomic features robust enough with respect to tumor delineation uncertainties?
32. EP-1319: “Adjuvant”/ radical radiotherapy in prostate cancer patients with synchronous bone oligometastasis
33. EP-1315: Prostate cancer lymph nodal disease: SBRT only or extensive prophylactic irradiation and boost?
34. PO-0886: Early changes of FDG-PET markers predict the outcome after chemo-radiotherapy for pancreatic cancer
35. P.11.20: Real-Life Prospective Experience with Adalimumab in Inducing Remission in Ulcerative Colitis in Primary Inflammatory Bowel Diseases Centres
36. P.07.7: Impact of Endoscopic Classification “Dica” on the Burden of Diverticular Disease of the Colon in Italy
37. P.02.10: Bismuth-Containing Quadruple Therapy in Patients Infected by Helicobacter Pylori: A First Real Life Italian Experience
38. OC.09.6: Assessment of Small Bowel Enteropathy in Patients Taking Aminosalycilic Acid and/or Proton-Pump Inhibitors: A Primary Care Study
39. OC.10.2: Fecal Microbiota, Fecal and Urinary Metabolic Profiling and Symptomatic Uncomplicated Diverticular Disease of the Colon
40. 392 - The effects of 18F-FDG PET/CT on the management and prognosis of patients with bladder cancer (BCa) and upper urinary tract urothelial carcinoma (UTUC)
41. 386 - Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) and morphological imaging in recurrent urothelial carcinomas: A retrospective, multi-center study
42. P.09.12 ASSESSMENT OF FECAL MICROBIOTA AND FECAL METABOLOME IN SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE OF THE COLON
43. PC.01.2 PREDICTIVE VALUE OF THE “DICA” ENDOSCOPIC CLASSIFICATION ON THE OUTCOME OF THE DIVERTICULAR DISEASE OF THE COLON: AN INTERNATIONAL STUDY
44. 930 [11C]Choline PET/CT predicts survival in hormone-naïve prostate cancer patients with biochemical failure after radical prostatectomy
45. EP-1157 FDG-PET guided dose escalation with TomoTherapy for locally advanced oropharyngeal cancer
46. 265 Assessing the optimal extent of salvage lymph node dissection in patients with single pelvic nodal uptake at [11c]-choline pet/ct scan from recurring prostate cancer
47. 267 Long term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: Results of a single institution series with a minimum follow-up of 5 years
48. P.11.7 FECAL CALPROTECTIN IN PREDICTING RECURRENCE AFTER ATTACK OF COLONIC DIVERTICULITIS
49. P.11.6 MODERATE-TO-SEVERE AND PROLONGED LEFT LOWER ABDOMINAL PAIN IS THE BEST SYMPTOM CHARACTERIZING SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE OF THE COLON: A COMPARISON WITH FECAL CALPROTECTIN IN CLINICAL SETTING
50. P.06.25 INFLIXIMAB AND ADALIMUMAB FOR CROHN'S DISEASE IN REAL LIFE: EFFECTIVENESS, SAFETY AND ABILITY IN OBTAINING MUCOSAL AND HISTOLOGICAL HEALING
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.